- 24/7 Wall St.•20 hours ago
Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.
- Zacks•20 hours ago
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene
After hours: 64.810.09 (0.14%) as of 7:59 PM EDT
|Bid||63.64 x 100|
|Ask||65.69 x 100|
|52wk Range||45.45 - 70.79|
|Day's Range||63.93 - 65.06|
|Avg Vol (3m)||9,089,439|
As of 4:00 PM EDT. Market closed.